AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT01528748 — intervention group
Intervention type: BEHAVIORAL
Intervention: Cognitive Behavioral Analysis System of Psychotherapy
Description: Cognitive Behavioral Analysis System of Psychotherapy (CBASP) is a behavioral intervention that addresses the unique behavioral characteristics of chronically depressed individuals, most of which are highly relevant for alcoholics as well. CBASP has a structured, individualized, and collaborative (patient and clinician) design. The intervention emphasizes teaching effective coping strategies and employing motivational, cognitive, behavioral, and interpersonal techniques. Individual therapy (1 hour) sessions occur on a weekly basis for a total of 20 sessions over a period of 21 weeks.
Study NCT03070197 — intervention group
Intervention type: OTHER
Intervention: Exposure of interest: Brain MRI
Description: Brain MRI will be conducted in all participants
Study NCT03070197 — intervention group
Intervention type: OTHER
Intervention: Exposure of interest: neurodevelopmental assessments
Description: neurodevelopmental testing will be conducted in all participants.
Study NCT00821249 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ARRY-520, KSP(Eg5) inhibitor; intravenous
Description: Part 1: multiple dose, escalating; Part 2: multiple dose, single schedule; Part 3: multiple dose, single schedule.
Study NCT00821249 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Filgrastim, granulocyte-colony stimulating factor (G-CSF); subcutaneous
Description: Part 1: standard of care; Part 2: standard of care; Part 3: standard of care.
Study NCT00821249 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone, steroid; oral
Description: Part 3: standard of care.
Study NCT03864393 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Multimodal overground locomotor training
Description: Locomotor training sessions use various movement drills emphasizing power, stability, and stepping in a specific direction: forward, backward, lateral, rotational. Sessions also have an additional focus on gait initiation or steady-state walking. After circuit-style warm up exercises, participants perform overground movement drills that are specific to the emphasis of the individual training session, culminating in practicing everyday overground walking. Participants wear a heart rate monitor to ensure that the majority of the training session is performed at an aerobic intensity greater than 60% age predicted heart rate maximum (220-age +/- 5 bpm).
Study NCT02482857 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Acetylsalicylic acid
Description: To compare BID dosing with OD dosing with clinically used aspirin dosages.
Study NCT02482857 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid
Description: To compare BID dosing with OD dosing with clinically used aspirin dosages.
Study NCT02565810 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adalimumab PFS and Pen
Study NCT01608503 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: lung deflation
Description: lung was deflated during respiration cycle
Study NCT01608503 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: lung inflation
Description: lung was inflated during respiratory cycle
Study NCT02776592 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cow's milk-based formula with added nutrients
Study NCT02776592 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Cow's milk-based formula
Study NCT03833713 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: SMS Dialogue
Description: Once-weekly SMS dialogue sessions or micro-interventions and use behavior change techniques (BCTs) including self-monitoring with performance feedback and goal support
Study NCT03833713 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: SMS Assessments
Description: Once-weekly SMS assessments of motor vehicle risks
Study NCT02995551 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Arthroscopic meniscal repair or resection
Description: Arthroscopic meniscal repair or resection following standard procedures.
Study NCT02995551 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Exercise and education
Description: A 12-week (2 exercise sessions per week) supervised neuromuscular and strengthening exercise program tailored to 18-40 years old patients with a meniscal tear combined with patient education teaching the participants about their disease and how to manage it through exercise and in their daily life.
Study NCT04828291 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Benign Behavioral Interventions
Description: This project will use a Randomized Control Trial (RCT) design and Daily Reconstruction Method (DRM8) to model the effects of the OMI on dynamic changes in first-year undergraduate and graduate students' well-being over time. The intervention will take place over the course of 46 days, with a 7- day follow up assessment taking place one month after the intervention. People will complete surveys through an online link leading to Qualtrics.com.
Study NCT04828291 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Benign Behavioral Interventions
Description: This project will use a Randomized Control Trial (RCT) design and Daily Reconstruction Method (DRM8) to model the effects of the OMI on dynamic changes in first-year undergraduate and graduate students' well-being over time. The intervention will take place over the course of 46 days, with a 7- day follow up assessment taking place one month after the intervention. People will complete surveys through an online link leading to Qualtrics.com.
Study NCT03504566 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Linagliptin
Description: Linagliptin
Study NCT03504566 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Empagliflozin
Description: Empagliflozin
Study NCT03504566 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Telmisartan
Description: Telmisartan
Study NCT03504566 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Sulodexide
Description: Sulodexide
Study NCT04445623 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Prasugrel Hydrochloride 10 MG Oral Tablet
Description: administration of prasugrel daily for 15 days
Study NCT04445623 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: administration of placebo daily for 15 days
Study NCT04467970 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Unicompartmental Knee Replacement
Description: Unicompartmental Knee Replacement involves replacement of the medial compartment of the knee in patients with anteromedial osteoarthritis.
Study NCT04467970 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: High Tibial Osteotomy
Description: High Tibial Osteotomy involves medial wedge opening high tibial osteotomy in cases of anteromedial osteoarthritis.
Study NCT02170766 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BIBR 1048 low1
Study NCT02170766 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BIBR 1048 low2
Study NCT02170766 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BIBR 1048 medium
Study NCT02170766 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BIBR 1048 high
Study NCT02368652 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Candesartan cilexetil 16mg
Description: Daily oral administration for 8 weeks
Study NCT02368652 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amlodipine 10mg, Candesartan cilexetil 16mg
Description: Daily oral administration for 8 weeks
Study NCT02293551 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lispro
Description: Administered SC
Study NCT02170766 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pantoprazole
Study NCT02805595 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 23.4% Hypertonic saline
Description: Saline Injections
Study NCT02107872 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: REGN1500
Study NCT02107872 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: placebo
Study NCT02723175 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial Direct Current Stimulation
Description: Transcranial Direct Current Stimulation is a minimally invasive technique that uses a small amount of electricity (2mA) to temporarily stimulate specific brain areas in awake people.
Study NCT04596085 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Investigational Product - ViraCide
Description: Viracide
Study NCT04596085 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo - Starch Powder Soft gels
Description: Starch Powder Soft gels
Study NCT00139256 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Betamethasone
Description: Betamethasone injection
Study NCT00139256 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Betamethasone
Description: Betamethasone injection
Study NCT02259985 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Itasetron tablet
Study NCT02259985 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Itasetron tablet
Study NCT02259985 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Itasetron infusion
Study NCT02259985 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: high fat breakfast
Study NCT02577185 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Botulinum Toxin Type A
Study NCT02577185 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Sodium chloride 9 mg/ml
Study NCT00766974 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Anti-embolism Knee High Stocking
Description: Anti-embolism Knee High Compression Stocking
Study NCT00766974 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: 20-30 Knee High Compression Stocking
Description: 20-30 mmHg Knee High COmpression Stocking
Study NCT01786460 — intervention group
Intervention type: OTHER
Intervention: Blood draw at Days 0, 7, 14, and 21
Study NCT04405271 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Emtricitabine/Tenofovir Alafenamide 200 MG-25 MG Oral Tablet
Description: Emtricitabine/Tenofovir alafenamide (FTC/TAF) in 200 mg/25 mg tablets. A dose of 1 tablet per day will be administered for a total of 12 weeks
Study NCT04405271 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: A dose of 1 tablet per day will be administered for a total of 12 weeks.
Study NCT04409717 — intervention group
Intervention type: PROCEDURE
Intervention: Type II endoleak treatment
Description: Type II endoleak endovascular treatment
Study NCT00661388 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: methoxy polyethylene glycol-epoetin beta [Mircera]
Description: sc every month (starting dose 1.2 micrograms/kg)
Study NCT02094781 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Whey protein and creatine supplement
Description: Each sachet contained 30g whey protein powder and 5g creatine powder, administered twice a day. The first serving was consumed with breakfast and the second serving was consumed within 60 minutes of completing training or in the evening on non-training days. Participants also drank at least 2 litres of water per day
Study NCT02094781 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Whey protein only supplement
Description: Each sachet contained 30g of whey protein powder and 5g of bulking agent powder, administered twice a day. The first serving was consumed with breakfast and the second serving was consumed within 60 minutes of completing training or in the evening on non-training days. Participants also drank at least 2 litres of water per day
Study NCT02094781 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Each sachet contained 30g of isocaloric carbohydrate powder and 5g of bulking agent powder, administered twice a day. The first serving was consumed with breakfast and the second serving was consumed within 60 minutes of completing training or in the evening on non-training days. Participants also drank at least 2 litres of water per day
Study NCT00721136 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: continue warfarin through the procedure
Description: The usual dose of warfarin (resulting in a therapeutic INR) is taken throughout the peri-procedural period.
Study NCT00721136 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Hold warfarin
Description: For moderate risk patients, warfarin will be held for 4-5 days prior to the procedure.
Study NCT00721136 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Warfarin held with heparin transition.
Description: For high risk patients, warfarin is held for 4-5 days prior to the procedure and heparin is given to provide anticoagulation while the INR is subtherapeutic.
Study NCT01749930 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BOL-303259-X
Description: BOL-303259-X will be administered QD in the evening and its vehicle administered QD in the morning
Study NCT01749930 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Timolol
Description: Timolol will be administered BID once in the morning and once in the evening.
Study NCT01749930 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BOL-303259-X
Description: All participants will receive a topical ocular BOL-303259-X QD in the evening from 3 months (Visit 6) through 6 months (Visit7).
Study NCT01749930 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: BOL-303259-X
Description: All participants will receive a topical ocular BOL-303259-X QD in the evening from 3 months (Visit 6) through 6 months (Visit7).
Study NCT03533192 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: It's Your Game...Keep it Real
Description: It's Your Game...Keep it Real consists of 12 50-minute lessons delivered in 7th grade (8 in class and 4 via computer) and 12 50-minute lessons delivered in 8th grade (7 in class and 5 via computer). In each grade, the curriculum integrates group-based classroom activities with personalized journaling and individually tailored computer-based activities. A life-skills decision-making paradigm (Select, Detect, Protect) underlies the activities, teaching students to select personal rules regarding risk behaviors, detect signs or situations that might challenge these rules, and use refusal skills and other tactics to protect these rules. The curriculum is grounded in social cognitive theory, the theory of triadic influence, and social influence models.
Study NCT02067299 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JNJ-42847922
Description: Participants will receive suspension of JNJ-42847922 (10 mg, 20 mg, and 40 mg) orally on Day 1 of the appropriate treatment periods.
Study NCT02067299 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Participants will receive placebo orally on Day 1 of the appropriate treatment periods.
Study NCT00631527 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Leuprolide
Description: Injections given through a needle in the muscle every 3 months.
Study NCT00631527 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Goserelin
Description: Subcutaneous injections given once every 3 months.
Study NCT00631527 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sunitinib Malate
Description: Starting dose of 12.5 mg by mouth daily for 4 weeks
Study NCT02363322 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: B/Current Standard of Care Plus ZMapp
Description: Triple monoclonal cocktail of antibodies against Zaire species of Ebola virus
Study NCT02363322 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: A/Current Standard of Care Alone
Description: Optimized standard of care for Ebola virus infection
Study NCT01028066 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Traditional
Description: The control group will have access to the nutritionist to clear any doubts about the diet prescribed when went out the hospital and will be invited to attend a meeting nutrition in dialogic character at the end of 1 year to ensure fairness in action.
Study NCT01028066 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral
Description: The intervention group will go through 4 meetings of food education, to be held within the institution, with approximately 1 hour long, composed of 3 to 8 patients, who may or may not be accompanied by a relative. The first three meetings will be monthly and the fourth will be 6 months after the last one. Each meeting will be developed within the context of dialogic and participatory education, directed to the adoption of a healthy diet and prevention and control of cardiovascular risk factors. The meetings will follow the order: Investigation, Contextualization, Awareness and Strengthening the nutritional concepts, according to the didactics of educator Paulo Freire.
Study NCT00930436 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: sodium bicarbonate
Description: Serum creatinine will be measured on Days 3,7, 30, 90, and 180
Study NCT00930436 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: sodium bicarbonate
Description: Serum creatinine will be measured on Days 3,7, 30, 90, and 180
Study NCT01431885 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Diagnosis by cervical length and fibronectin
Description: Diagnosis will be made by MOD Algorithm B
Study NCT01431885 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Cervical change
Description: Diagnosis will be made by digital examination of cervical change
Study NCT00473525 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo QD
Study NCT00473525 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-00734200 10 mg QD
Description: 10 mg QD
Study NCT00473525 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-00734200 20 mg QD
Description: 20 mg QD
Study NCT00473525 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-00734200 5 mg QD
Description: 5 mg QD
Study NCT00473525 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-00734200 2 mg QD
Description: 2 mg QD
Study NCT01092793 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Krill
Description: Encapsulated oil from the antarctic crustacean Krill
Study NCT01092793 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Fish oil
Description: Encapsulated, raffined cod-oil
Study NCT00049595 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: bleomycin sulfate
Study NCT00049595 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: bleomycin sulfate
Study NCT00049595 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: filgrastim
Study NCT00049595 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: pegfilgrastim
Study NCT00049595 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ABVD regimen
Study NCT00049595 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BEACOPP regimen
Study NCT00049595 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cyclophosphamide
Study NCT00049595 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: dacarbazine
Study NCT00049595 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: doxorubicin hydrochloride
Study NCT00049595 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: doxorubicin hydrochloride
Study NCT00049595 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: etoposide
Study NCT00049595 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: prednisone
Study NCT00049595 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: procarbazine hydrochloride
Study NCT00049595 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: vinblastine sulfate
Study NCT00049595 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: vincristine sulfate
Study NCT04942223 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: guided bone regeneration
Description: After local anesthesia, the surgery started with a mid-crestal incision with vertical releasing cuts followed by the full-thickness buccal and lingual/palatal flaps raising to expose the bone defect completely. The flaps were coronally extended to assure a complete closure with a passive suture above the titanium. Subsequently, an intra-oral mandibular ramus bone cortical block was harvested in the molar zone. The bone block was milled and mixed with freeze-dried. The particulate graft was put to fill the deficit above the mesh until its perfect stability and unity with the defect's borders. Two or three titanium mini-screws were used to stabilize the device , and the flaps were carefully sutured. Ceftriaxone was administered intravenously at a loading dose of 2 g; together with a non-steroidal analgesic, it was continued at two g/die per os beginning the day after surgery and continuing for six days.
Study NCT03530332 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: PreTRM test
Description: Blood test to determine risk of preterm birth
Study NCT04004403 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Alternate day fasting
Description: The diet involves consuming 600 kcal on the fast day and eat ad libitum at home on alternating feed days.